MYGN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Myriad Genetics Inc's quarterly cash and cash equivalents declined from Sep. 2013 ($85.0 Mil) to Dec. 2013 ($71.6 Mil) but then increased from Dec. 2013 ($71.6 Mil) to Mar. 2014 ($85.8 Mil).
Myriad Genetics Inc's annual cash and cash equivalents increased from Jun. 2011 ($52.7 Mil) to Jun. 2012 ($86.4 Mil) and increased from Jun. 2012 ($86.4 Mil) to Jun. 2013 ($104.1 Mil).
Cash and cash equivalents on banks book.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Myriad Genetics Inc Annual Data
Myriad Genetics Inc Quarterly Data